Page last updated: 2024-09-05
dabigatran and enalapril
dabigatran has been researched along with enalapril in 2 studies
Compound Research Comparison
Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (enalapril) | Trials (enalapril) | Recent Studies (post-2010) (enalapril) |
---|---|---|---|---|---|
3,887 | 261 | 3,490 | 6,311 | 1,924 | 859 |
Protein Interaction Comparison
Protein | Taxonomy | dabigatran (IC50) | enalapril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.3536 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 2.7083 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 1.2 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.14 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.14 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
Brodsky, SV; Ivanov, I; Medipally, AK; Qaisar, S; Rovin, BH; Satoskar, AA; Xiao, M | 1 |
Other Studies
2 other study(ies) available for dabigatran and enalapril
Article | Year |
---|---|
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Role of glomerular filtration rate-modifying drugs in the development of anticoagulant-related nephropathy.
Topics: Acute Kidney Injury; Albuterol; Animals; Antihypertensive Agents; Antithrombins; Bronchodilator Agents; Dabigatran; Disease Models, Animal; Enalapril; Glomerular Filtration Rate; Male; Nephrectomy; Rats; Rats, Sprague-Dawley | 2021 |